Bond, David A. http://orcid.org/0000-0003-0773-1829
Huang, Ying
Fisher, James L.
Ruppert, Amy S.
Owen, Dwight H.
Bertino, Erin M.
Rogers, Kerry A.
Bhat, Seema A.
Grever, Michael R.
Jaglowski, Samantha M.
Maddocks, Kami J.
Byrd, John C.
Woyach, Jennifer A.
Article History
Received: 31 December 2019
Revised: 10 July 2020
Accepted: 14 July 2020
First Online: 23 July 2020
Compliance with ethical standards
:
: KAR has consulted for Acerta Pharma, AstraZeneca, and Pharmacyclics, has received travel funding from Astra Zeneca, and has received research funding from Genentech, AbbVie, and Janssen. SAB has consulted for Pharmacyclics and Janssen. MRG has served on an advisory committee for Acerta Pharma. SMJ has received research funding from Pharmacyclics. JCB has consulted for Janssen, received travel support from TG Therapeutics, Janssen, Pharmacyclics, and Gilead, served on speakers bureau for Gilead, Pharmacyclics, Janssen, Novartis, and TG Therapeutics, and received research funding from Gilead, Acerta, BeiGene, Janssen, Genentech, Pharmacyclics, and TG Therapeutics. JAW has consulted for Janssen, Pharmacyclics, AstraZeneca, and Arqule and has received research funding from Janssen, Pharmacyclics, Loxo, and Arqule. DAB, YH, JLF, ASR, DHO, EMB, and KJM have no relevant competing interests.